US Patent 10370431 Optimized factor VIII gene
Patent 10370431 was granted and assigned to Bioverativ on August, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+264 characters)
Article
Patent abstract
The present invention provides codon optimized Factor VIII sequences, vectors and host cells comprising codon optimized Factor VIII sequences, polypeptides encoded by codon optimized Factor VIII sequences, and methods of producing such polypeptides.
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Robert T. Peters0
Siyuan Tan0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103704310
Date of Patent
August 6, 2019
0Patent Application Number
147674250
Date Filed
February 14, 2014
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10370431 Optimized factor VIII gene
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10370431
Date of patent
August 6, 2019
Patent application number
14767425
Date Filed
February 14, 2014
Patent primary examiner
Find more entities like US Patent 10370431 Optimized factor VIII gene
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
